Expression of EphA4 on astrocytes inhibits neurite outgrowth. After spinal hemisection, EphA4 (a) and GFAP (b) are coexpressed as assessed by immunofluorescence on reactive astrocytes at the lesion site (c; a merged image of a and b). EphA4 was also expressed on some neurons (a-c, arrow). Western blot analysis (d) showed upregulation and phosphorylation of EphA4 (p-EphA4) at the lesion site (les) in comparison with unlesioned control (con) mice; * shows a nonspecific band present in all lanes. β-Actin was used as a loading control and EphA4-/- spinal cord as an EphA4 expression control. The EphA4 expression on astrocytes was inhibitory to cortical neuronal neurite outgrowth, because βIII-tubulin-positive cortical neurons on EphA4-/- astrocytes (e, g) had significantly longer neurites than on EphA4-expressing (EphA4+/+) astrocytes (f, g) after 22 hr (*p < 0.0001). EphA4-/- neurite outgrowth was also enhanced on EphA4-/- and EphA4+/+ astrocytes, compared with that of wild-type neurons (g; **p < 0.0001). h, The inhibition of neurite outgrowth by EphA4 on astrocytes could be blocked in a dose-dependent manner by addition of monomeric (mono) EphrinA5-Fc, but this had no effect on neurites grown on laminin. Multimerized (multi) EphrinA5-Fc inhibited neurite outgrowth both on astrocytes and on laminin (*p < 0.0001). Scale bars, 50 μm.